DBT: BOD resolution dated June 28, 2022
The Board resolution dated June 28, 2022, the BOD of BenTre Pharmaceutical Joint Stock Company approved the following comtents:
- Approved the plan for stock issuance under ESOP and stock dividend payment.
- Approved the adjustment of DBT’s organization chart.
- Approved the selection of Ernst & Young Vietnam Company Limited as the auditor for the financial statements in 2022.
- Approved the purchase of shares to increase the ownership ratio of DBT in Yen Bai Joint-stocks Pharmaceutical Company.